Clinical trial
Prospective, Observational, 12-month Assessment of Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in Canada (CANadian CAnagliflozin REgistry: CanCARE)
NCT02688075 is registered in ClinicalTrials.gov with Janssen Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Observational, 12-month Assessment of Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in Canada (CANadian CAnagliflozin REgistry: CanCARE)
- Lead sponsor
- Janssen Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 13, 2015
- Completion date
- August 17, 2017
- Enrollment
- 538 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.